VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients

被引:7
|
作者
Englert, F. [1 ]
Bahlke, F. [1 ]
Erhard, N. [1 ]
Krafft, H. [1 ]
Popa, M. -a. [1 ]
Risse, E. [1 ]
Lennerz, C. [1 ]
Lengauer, S. [1 ]
Telishevska, M. [1 ]
Reents, T. [1 ]
Kottmaier, M. [1 ]
Kolb, C. [1 ]
Hessling, G. [1 ]
Deisenhofer, I. [1 ]
Bourier, F. [1 ]
机构
[1] Tech Univ Munich TUM, German Heart Ctr Munich, Dept Electrophysiol, Lazarettstr 36, D-80636 Munich, Germany
关键词
VT ablation; inHEART; Cardiomyopathy; Wall thinning; Late enhancement; VENTRICULAR-TACHYCARDIA; SCAR;
D O I
10.1007/s00392-023-02321-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The eradication of ventricular tachycardia (VT) isthmus sites constitutes the minimal procedural endpoint for VT ablation procedures. Contemporary high-resolution computed tomography (CT) imaging, in combination with computer-assisted analysis and segmentation of CT data, facilitates targeted elimination of VT isthmi. In this context, inHEART offers digitally rendered three-dimensional (3D) cardiac models which allow preoperative planning for VT ablations in ischemic and non-ischemic cardiomyopathies. To date, almost no data have been collected to compare the outcomes of VT ablations utilizing inHEART with those of traditional ablation approaches.Methods The presented data are derived from a retrospective analysis of n = 108 patients, with one cohort undergoing VT ablation aided by late-enhancement CT and subsequent analysis and segmentation by inHEART, while the other cohort received ablation through conventional methods like substrate mapping and activation mapping. The ablations were executed utilizing a 3D mapping system (Carto3), with the mapping generated via the CARTO (R) PENTARAY (TM) NAV catheter and subsequently merged with the inHEART model, if available.Results Results showed more successful outcome of ablations for the inHEART group with lower VT recurrence (27% vs. 42%, p < 0.06). Subsequent analyses revealed that patients with ischemic cardiomyopathies appeared to derive a significant benefit from inHEART-assisted VT ablation procedures, with a higher rate of successful ablation (p = 0.05).Conclusion Our findings indicate that inHEART-guided ablation is associated with reduced VT recurrence compared to conventional procedures. This suggests that employing advanced imaging and computational modeling in VT ablation may be valuable for VT recurrences.
引用
收藏
页码:1478 / 1484
页数:7
相关论文
共 50 条
  • [1] Dystrophin: From non-ischemic cardiomyopathy to ischemic cardiomyopathy
    Zheng, Qiang Sun
    Guo, Wan Gang
    Lu, Zi Fan
    Shi, Xiao Qin
    Su, Fei Fei
    Li, Hua
    MEDICAL HYPOTHESES, 2008, 71 (03) : 434 - 438
  • [2] Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy
    Karthikeyan Ananthasubramaniam
    Ritesh Dhar
    João L. Cavalcante
    Heart Failure Reviews, 2011, 16 : 351 - 367
  • [3] Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy
    Ananthasubramaniam, Karthikeyan
    Dhar, Ritesh
    Cavalcante, Joao L.
    HEART FAILURE REVIEWS, 2011, 16 (04) : 351 - 367
  • [4] Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy
    Bhaskaran, Ashwin
    De Silva, Kasun
    Rao, Karan
    Campbell, Timothy
    Trivic, Ivana
    Bennett, Richard G.
    Kizana, Eddy
    Kumar, Saurabh
    KOREAN CIRCULATION JOURNAL, 2020, 50 (03) : 203 - 219
  • [5] Influence of Ischemic and Non-Ischemic Cardiomyopathy on Catheter Ablation for Atrial Fibrillation
    Arora, Shilpkumar
    Dave, Mihir
    Tripathy, Byomesh
    Lahewala, Sopan
    Patel, Nilay
    Patel, Nileshkumar
    Kumar, Varun
    Varma, Yash
    Malhotra, Shikha
    Gidwani, Umesh
    Badheka, Apurva
    Deshmukh, Abhishek
    Viles-Gonzalez, Juan F.
    CIRCULATION, 2018, 138
  • [6] Impact of VT pleomorphism on the prognostic value of non-inducibility after catheter ablation in patients with non-ischemic cardiomyopathy
    Kimura, Y.
    Ebert, M.
    Wijnmaalen, A. P.
    Trines, S.
    Silva, M. De Riva
    Zeppenfeld, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3571 - 3571
  • [7] Differences in the Outcomes of Catheter Ablation for Ventricular Tachycardia in Patients With Ischemic versus Non-Ischemic Cardiomyopathy
    Woelber, Tiffany
    Dhawan, Rahul
    Dai, Qiying
    Desimone, Christopher V.
    Killu, Ammar M.
    Siontis, Konstantinos
    Deshmukh, Abhishek
    Kowlgi, Gurukripa N.
    CIRCULATION, 2023, 148
  • [8] Myocardial perfusion imaging in non-ischemic cardiomyopathy
    Patel, Haren
    Prejean, Shane
    Iskandrian, Ami E.
    Hage, Fadi G.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (03) : 1028 - 1032
  • [9] Early results with cardiac support device implant in patients with ischemic and non-ischemic cardiomyopathy
    Franco-Cereceda, A
    Lockwandt, U
    Olsson, A
    Bredin, F
    Forssell, G
    Öwall, A
    Runsiö, M
    Liska, J
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2004, 38 (03) : 159 - 163
  • [10] Catheter ablation of ventricular tachycardia: Characterization of scars in ischemic and non-ischemic cardiomyopathy
    Cesario, D
    Vaseghi, M
    Ji, S
    Valderrabano, M
    Shannon, K
    Boyle, N
    Natterson, B
    Wiener, I
    Shivkumar, K
    CIRCULATION, 2005, 112 (17) : U685 - U685